🇺🇸 FDA

Company profile · Sponsor

RECURSION

RECURSION PHARMACEUTICALS, INC.

RXRX · NYSE biotech SALT LAKE CITY, UT, USA
Pipeline
9
Drugs
0
Patents
4

Quick answer

RECURSION (RXRX) is a biotech company. headquartered in SALT LAKE CITY, UT, USA. listed on NYSE. NovaPharmaNews links 9 pipeline programs, 0 drugs, and 4 patents to this profile..

Company facts

Ticker RXRX
Exchange NYSE
Company type biotech
Headquarters SALT LAKE CITY, UT, USA
SEC CIK 0001601830

Pipeline (9)

Search pipeline →

  1. REC-2282

    RECURSION

    Neurofibromatosis Type 2

    phase 3 small molecule terminated

    1 trial

  2. GTAEXS617

    RECURSION

    Head and Neck Squamous Cell Carcinoma (HNSCC)

    phase 2 small molecule active

    1 trial

  3. REC-1245

    RECURSION

    Unresectable

    phase 2 small molecule active

    1 trial

  4. REC-3964

    RECURSION

    Recurrent Clostridioides Difficile Infection

    phase 2 small molecule terminated

    1 trial

  5. REC-4881

    RECURSION

    AXIN1 Gene Mutation

    phase 2 small molecule terminated

    1 trial

  6. REC-4881

    RECURSION

    Familial Adenomatous Polyposis

    phase 2 small molecule active

    1 trial

  7. REC-994

    RECURSION

    Cerebral Cavernous Malformation

    phase 2 small molecule completed

    1 trial

  8. EXS73565

    RECURSION

    Relapsed or Refractory B-cell Malignancies

    phase 1 small molecule active

    1 trial

  9. EXS74539

    RECURSION

    Solid Tumor

    phase 1 small molecule active

    1 trial

Patents (4)

Search patents →

  1. US 11919868

    Heterocyclic compounds and related methods

    Expires Mon Feb 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11033494

    Apparatuses containing an emulsion and methods of manufacture

    Expires Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 6331564

    Use of triaryl methane compounds for inhibiting unwanted cellular proliferation associated with inflammatory disease

    Expires Mon Dec 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  4. US 6028103

    Triaryl methane compounds and analogues thereof useful for the treatment or prevention of sickle cell disease or diseases characterized by abnormal cell proliferation

    Expires Mon Feb 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

What is RECURSION?

RECURSION (RXRX) is a biotech company. headquartered in SALT LAKE CITY, UT, USA. listed on NYSE. NovaPharmaNews links 9 pipeline programs, 0 drugs, and 4 patents to this profile..

What pipeline programs does RECURSION sponsor?

We track 9 ClinicalTrials.gov-linked programs for RECURSION, including REC-2282 and 8 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does RECURSION company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.